MEDICINAL PHARMACEUTICAL PREPARATION NAMELY

Brand	Owner (click to sort)	Address	Description
ALDACTAZIDE	WYETH HOLDINGS	235 East 42nd Street New York NY 10017	Medicinal and Pharmaceutical Preparation-Namely, a Diuretic;
ALDACTAZIDE-A	G. D. SEARLE & CO.	Skokie IL	MEDICINAL AND PHARMACEUTICAL PREPARATION-NAMELY, ADIURETIC;
BRIMOS	BRISTOL-MYERS COMPANY	New York NY	MEDICINAL AND PHARMACEUTICAL PREPARATION-NAMELY, AN ANTACID ANALGESIC TABLET;
BRISTAB	BRISTOL-MYERS COMPANY	New York NY	MEDICINAL AND PHARMACEUTICAL PREPARATION-NAMELY, A DIURETIC;
CEFA-TABS	BRISTOL-MYERS COMPANY	New York NY	Medicinal and Pharmaceutical Preparation-Namely, an Antibiotic for Veterinary Use;

DICLOXIN	BRISTOL-MEYERS COMPANY	630 5TH AVE. NEW YORK NY	MEDICINAL AND PHARMACEUTICAL PREPARATION-NAMELY, AN ANTIBIOTIC;
DICLOXIN	BRISTOL-MYERS COMPANY	New York NY	Medicinal and Pharmaceutical Preparation-Namely, an Oral Antibiotic for Veterinary Use;
DYNAPEN	E. R. SQUIBB & SONS	Lawrenceville-Princeton Road Princeton NJ 08540	Medicinal and Pharmaceutical Preparation-Namely, an Oral Antibiotic;
INJECT-ALL	LYPHOMED, INC.	2020 RUBY ST. MELROSE PARK IL 60160	Medicinal and Pharmaceutical Preparation-Namely, a Single Dose Syringe Containing an Antiarrhythmic Preparation;
KETAJECT	BRISTOL-MYERS COMPANY	New York NY	Medicinal and Pharmaceutical Preparation-Namely, an Injectable Anesthetic for Intravenous or Intramuscular Use;
LYSODREN	LABORATOIRE HRA-PHARMA SAS	200 Avenue de Paris CHATILLON 92320 France	Medicinal and Pharmaceutical Preparation-Namely, an Oral Anti-Cancer Drug;
VERSAPEN	BRISTOL-MYERS COMPANY	New York NY	MEDICINAL AND PHARMACEUTICAL PREPARATION-NAMELY, AN ANTIBIOTIC;
	Where the owner name is not linked, that owner no longer owns the brand

Technical Examples

The present invention provides medicinal or pharmaceutical compositions and preparations for administration, which are useful as cytoprotective agents and a remedy for neurotrauma, comprising ginseng, its extract, ginseng components, metabolites thereof or salts thereof (for example, red ginseng powder or components thereof). More particularly, the present invention provides medicinal or pharmaceutical compositions for inhibiting apoptosis or apoptosis-like cell death, medicinal or pharmaceutical compositions for promoting the expression of a cell death-suppressing gene product Bcl-xL, or preparations for oral or intravenous administration, comprising ginseng, its extracts, ginseng components, metabolites thereof or salts thereof preferably at low concentrations. These medicinal or pharmaceutical compositions and/or preparations for administration are characterized by containing, as the active ingredient(s), ginseng, its extracts, ginseng components, metabolites thereof or salts thereof at low concentrations. These drugs are useful for therapy, prevention or treatment of brain and nervous diseases, heart diseases, etc.